Table 2.
Outcome Measure | Dedicated Device (n = 72) |
Vial (n = 72) |
p Value (Two-Sided) |
---|---|---|---|
Primary endpoint | |||
Freedom from DOCE | 51 (70.8%) | 60 (83.3%) | 0.11 |
Secondary endpoints | 68 (94.4%) | 69 (95.8%) | 1.0 |
Distribution of outcomes | |||
No complication | 51 (70.8%) | 60 (83.3%) | |
Hematoma | 20 (27.8%) | 11 (15.3%) | 0.13 |
Pseudoaneurysm | 1 (1.4%) | 0 (0.0%) | |
Radial artery occlusion | 0 (0.0%) | 1 (1.4%) | |
Compression time (min) | 120.0 (110.0–180) | 120.0 (100.0–142.5) | 0.28 |
DOCE—device oriented complex endpoint.